CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 44,566 shares, an increase of 600.7% from the February 12th total of 6,360 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 4,555,419 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 4,555,419 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
CV Sciences Stock Performance
Shares of OTCMKTS:CVSI traded up $0.00 during midday trading on Wednesday, hitting $0.05. 699,427 shares of the stock were exchanged, compared to its average volume of 1,230,479. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10. The company has a 50 day moving average price of $0.05 and a 200-day moving average price of $0.04. The company has a current ratio of 1.07, a quick ratio of 0.21 and a debt-to-equity ratio of 0.33.
About CV Sciences
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Further Reading
- Five stocks we like better than CV Sciences
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
